Aqueous Chemistry of the VanadiumIII (VIII) and the VIII−Dipicolinate Systems and a Comparison of the Effect of Three Oxidation States of Vanadium Compounds … P Buglyó, DC Crans, EM Nagy, RL Lindo, L Yang, JJ Smee, W Jin, LH Chi, ... Inorganic Chemistry 44 (15), 5416-5427, 2005 | 177 | 2005 |
Interactions of oxovanadium (IV) and the quinolone family member—ciprofloxacin I Turel, A Golobič, A Klavžar, B Pihlar, P Buglyo, E Tolis, D Rehder, ... Journal of inorganic biochemistry 95 (2-3), 199-207, 2003 | 117 | 2003 |
Oxidation of 2-Propanol and Cyclohexane by the Reagent “Hydrogen Peroxide− Vanadate Anion− Pyrazine-2-carboxylic Acid”: Kinetics and Mechanism YN Kozlov, VB Romakh, A Kitaygorodskiy, P Buglyó, G Süss-Fink, ... The Journal of Physical Chemistry A 111 (32), 7736-7752, 2007 | 113 | 2007 |
A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants M Andrasi, P Buglyo, L Zekany, A Gaspar Journal of pharmaceutical and biomedical analysis 44 (5), 1040-1047, 2007 | 109 | 2007 |
Speciation and NMR relaxation studies of VO (IV) complexes with several O-donor containing ligands: oxalate, malonate, maltolate and kojate P Buglyó, E Kiss, I Fábián, T Kiss, D Sanna, E Garribba, G Micera Inorganica Chimica Acta 306 (2), 174-183, 2000 | 109 | 2000 |
Oxovanadium (IV) complexes of citric and tartaric acids in aqueous solution T Kiss, P Buglyó, D Sanna, G Micera, P Decock, D Dewaele Inorganica chimica acta 239 (1-2), 145-153, 1995 | 102 | 1995 |
A quantitative study of the biotransformation of insulin-enhancing VO2+ compounds D Sanna, P Buglyó, G Micera, E Garribba JBIC Journal of Biological Inorganic Chemistry 15, 825-839, 2010 | 93 | 2010 |
Suberoylanilide hydroxamic acid, a potent histone deacetylase inhibitor; its X-ray crystal structure and solid state and solution studies of its Zn (II), Ni (II), Cu (II) and … DM Griffith, B Szőcs, T Keogh, KY Suponitsky, E Farkas, P Buglyó, ... Journal of Inorganic Biochemistry 105 (6), 763-769, 2011 | 90 | 2011 |
Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum D Sanna, L Bíró, P Buglyó, G Micera, E Garribba Journal of Inorganic Biochemistry, 2012 | 79 | 2012 |
A New Family of Insulin‐Mimetic Vanadium Complexes Derived from 5‐Carboalkoxypicolinates J Gätjens, B Meier, T Kiss, EM Nagy, P Buglyó, H Sakurai, K Kawabe, ... Chemistry–A European Journal 9 (20), 4924-4935, 2003 | 77 | 2003 |
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug D Sanna, V Ugone, G Micera, P Buglyó, L Bíró, E Garribba Dalton Transactions 46 (28), 8950-8967, 2017 | 74 | 2017 |
Vanadyl− Thiazolidinedione combination agents for diabetes therapy T Storr, D Mitchell, P Buglyó, KH Thompson, VG Yuen, JH McNeill, ... Bioconjugate chemistry 14 (1), 212-221, 2003 | 71 | 2003 |
The system VO2+ - oxidized glutathione: a potentiometric and spectroscopic study J Costa Pessoa, I Tomaz, T Kiss, P Buglyo Journal of Inorganic Biochemistry 84 (3), 259-270, 2001 | 70 | 2001 |
The systems VIVO2+-glutathione and related ligands: a potentiometric and spectroscopic study J Pessoa, I Tomaz, T Kiss, E Kiss, P Buglyó JBIC Journal of Biological Inorganic Chemistry 7, 225-240, 2002 | 65 | 2002 |
Biotransformation of BMOV in the presence of blood serum proteins D Sanna, L Bíró, P Buglyó, G Micera, E Garribba Metallomics 4 (1), 33-36, 2012 | 64 | 2012 |
VO2+ and Cu2+ complexation by ligands based on pyridine nitrogen donors E Garribba, D Sanna, P Buglyo, I Tomaz, JC Pessoa, S Borović, G Micera Dalton Transactions, 2012 | 62* | 2012 |
An iron-based molecular redox switch as a model for iron release from enterobactin via the salicylate binding mode TR Ward, A Lutz, SP Parel, J Ensling, P Gütlich, P Buglyó, C Orvig Inorganic chemistry 38 (22), 5007-5017, 1999 | 57 | 1999 |
Complexes of aminophosphonates—10. Copper (II) complexes of phosphonic derivatives of iminodiacetate and nitrilotriacetate P Buglyó, T Kiss, M Dyba, M Jezowska-Bojczuk, H Kozlowski, S Bouhsina Polyhedron 16 (19), 3447-3454, 1997 | 57 | 1997 |
Hydrolytic behaviour and chloride ion binding capability of [Ru (η 6-p-cym)(H 2 O) 3] 2+: A solution equilibrium study L Bíró, E Farkas, P Buglyó Dalton Transactions 41 (1), 285-291, 2012 | 52 | 2012 |
Complex formation between Ru (η 6-p-cym)(H 2 O) 3] 2+ and (O, O) donor ligands with biological relevance in aqueous solution L Bíró, E Farkas, P Buglyó Dalton Transactions 39 (42), 10272-10278, 2010 | 51 | 2010 |